LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

Carl Christoph Schimanski; Markus Möhler; Michael Schön; Eric van Cutsem; Richard Greil; Wolf Otto Bechstein; Susanna Hegewisch-Becker; Götz von Wichert; Matthias Vöhringer; Michael Heike; Volker Heinemann; Marc Peeters; Stephan Kanzler; Stefan Kasper; Friedrich Overkamp; Jan Schröder; Daniel Seehofer; Frank Kullmann; Bernhard Linz; Irene Schmidtmann; Victoria Smith-Machnow; Ines Gockel; Hauke Lang; Peter R Galle

doi:10.1186/1471-2407-12-144

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

Carl Christoph Schimanski, Markus Möhler, Michael Schön, Eric van Cutsem, Richard Greil (Co-author), Wolf Otto Bechstein, Susanna Hegewisch-Becker, Götz von Wichert, Matthias Vöhringer, Michael Heike, Volker Heinemann, Marc Peeters, Stephan Kanzler, Stefan Kasper, Friedrich Overkamp, Jan Schröder, Daniel Seehofer, Frank Kullmann, Bernhard Linz, Irene SchmidtmannVictoria Smith-Machnow, Ines Gockel, Hauke Lang, Peter R Galle

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

16 Citations (Web of Science)

Original language	English
Pages (from-to)	144
Journal	BMC CANCER
Volume	12
DOIs	https://doi.org/10.1186/1471-2407-12-144
Publication status	Published - 2012

Keywords

RESECTABLE LIVER METASTASES
ADJUVANT CHEMOTHERAPY
CANCER STATISTICS
EPISIALIN MUC1
CELL-ADHESION
FOLINIC ACID
TUMOR-CELLS
SURGERY
NEOADJUVANT
RECURRENCE

Access to Document

10.1186/1471-2407-12-144

Cite this

Schimanski, C. C., Möhler, M., Schön, M., van Cutsem, E., Greil, R., Bechstein, W. O., Hegewisch-Becker, S., von Wichert, G., Vöhringer, M., Heike, M., Heinemann, V., Peeters, M., Kanzler, S., Kasper, S., Overkamp, F., Schröder, J., Seehofer, D., Kullmann, F., Linz, B., ... Galle, P. R. (2012). LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial. BMC CANCER, 12, 144. https://doi.org/10.1186/1471-2407-12-144

@article{a0e926f01cb0488694ca234b773e15c1,

title = "LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.",

keywords = "RESECTABLE LIVER METASTASES, ADJUVANT CHEMOTHERAPY, CANCER STATISTICS, EPISIALIN MUC1, CELL-ADHESION, FOLINIC ACID, TUMOR-CELLS, SURGERY, NEOADJUVANT, RECURRENCE",

author = "Schimanski, {Carl Christoph} and Markus M{\"o}hler and Michael Sch{\"o}n and {van Cutsem}, Eric and Richard Greil and Bechstein, {Wolf Otto} and Susanna Hegewisch-Becker and {von Wichert}, G{\"o}tz and Matthias V{\"o}hringer and Michael Heike and Volker Heinemann and Marc Peeters and Stephan Kanzler and Stefan Kasper and Friedrich Overkamp and Jan Schr{\"o}der and Daniel Seehofer and Frank Kullmann and Bernhard Linz and Irene Schmidtmann and Victoria Smith-Machnow and Ines Gockel and Hauke Lang and Galle, {Peter R}",

note = "Third Department of Internal Medicine, University Medical Center (UMC), University Hospital of Salzburg, Salzburg, Austria ",

year = "2012",

doi = "10.1186/1471-2407-12-144",

language = "English",

volume = "12",

pages = "144",

journal = "BMC CANCER",

issn = "1471-2407",

publisher = " BioMed Central",

}

Schimanski, CC, Möhler, M, Schön, M, van Cutsem, E, Greil, R, Bechstein, WO, Hegewisch-Becker, S, von Wichert, G, Vöhringer, M, Heike, M, Heinemann, V, Peeters, M, Kanzler, S, Kasper, S, Overkamp, F, Schröder, J, Seehofer, D, Kullmann, F, Linz, B, Schmidtmann, I, Smith-Machnow, V, Gockel, I, Lang, H & Galle, PR 2012, 'LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.', BMC CANCER, vol. 12, pp. 144. https://doi.org/10.1186/1471-2407-12-144

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial. / Schimanski, Carl Christoph; Möhler, Markus; Schön, Michael et al.
In: BMC CANCER, Vol. 12, 2012, p. 144.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

AU - Schimanski, Carl Christoph

AU - Möhler, Markus

AU - Schön, Michael

AU - van Cutsem, Eric

AU - Greil, Richard

AU - Bechstein, Wolf Otto

AU - Hegewisch-Becker, Susanna

AU - von Wichert, Götz

AU - Vöhringer, Matthias

AU - Heike, Michael

AU - Heinemann, Volker

AU - Peeters, Marc

AU - Kanzler, Stephan

AU - Kasper, Stefan

AU - Overkamp, Friedrich

AU - Schröder, Jan

AU - Seehofer, Daniel

AU - Kullmann, Frank

AU - Linz, Bernhard

AU - Schmidtmann, Irene

AU - Smith-Machnow, Victoria

AU - Gockel, Ines

AU - Lang, Hauke

AU - Galle, Peter R

N1 - Third Department of Internal Medicine, University Medical Center (UMC), University Hospital of Salzburg, Salzburg, Austria

PY - 2012

Y1 - 2012

KW - RESECTABLE LIVER METASTASES

KW - ADJUVANT CHEMOTHERAPY

KW - CANCER STATISTICS

KW - EPISIALIN MUC1

KW - CELL-ADHESION

KW - FOLINIC ACID

KW - TUMOR-CELLS

KW - SURGERY

KW - NEOADJUVANT

KW - RECURRENCE

U2 - 10.1186/1471-2407-12-144

DO - 10.1186/1471-2407-12-144

M3 - Original Article

C2 - 22494623

SN - 1471-2407

VL - 12

SP - 144

JO - BMC CANCER

JF - BMC CANCER

ER -